Leucine Supplementation Improves Acquired Growth Hormone Resistance in Rats with Protein-Energy Malnutrition

Background Protein-energy malnutrition (PEM) can lead to growth hormone (GH) resistance. Leucine supplementation diets have been shown to increase protein synthesis in muscles. Our study aimed at investigating if long-term leucine supplementation could modulate GH-insulin-like growth factor (IGF)-1 system function and mammalian target of rapamycin (mTOR)-related signal transduction in skeletal muscles in a rat model of severe malnutrition. Methodology/Principal Findings Male Sprague-Dawley rats (n = 50; weight, 302 ± 5 g) were divided into 5 treatment groups, including 2 control groups (a normal control group that was fed chow and ad libitum water [CON, n = 10] and a malnourished control group [MC, n = 10] that was fed a 50% chow diet). After undergoing a weight loss stage for 4 weeks, rats received either the chow diet (MC-CON, n = 10), the chow diet supplemented with low-dose leucine (MC-L, n = 10), or the chow diet supplemented with high-dose leucine (MC-H, n = 10) for 2 weeks. The muscle masses of the gastrocnemius, soleus, and extensor digitorum longus were significantly reduced in the MC group. Re-feeding increased muscle mass, especially in the MC-L and MC-H groups. In the MC group, serum IGF-1, IGF-binding protein (IGFBP)-3, and hepatic growth hormone receptor (GHR) levels were significantly decreased and phosphorylation of the downstream anabolic signaling effectors protein kinase B (Akt), mTOR, and ribosomal protein S6 kinase 1 (S6K1) were significantly lower than in other groups. However, serum IGF-1 and IGF binding protein (IGFBP)-3 concentrations and hepatic growth hormone receptor (GHR) levels were significantly higher in the MC-L and MC-H groups than in the MC-CON group, and serum IGFBP-1 levels was significantly reduced in the MC-L and MC-H groups. These changes were consistent with those observed for hepatic mRNA expression levels. Phosphorylation of the downstream anabolic signaling effectors Akt, mTOR, and S6K1 were also significantly higher in the MC-L and MC-H groups than in the MC-CON group. Conclusion/Significance Our data are the first to demonstrate that long-term supplementation with leucine improved acquired growth hormone resistance in rats with protein-energy malnutrition. Leucine might promote skeletal muscle protein synthesis by regulating downstream anabolic signaling transduction.

[1]  L. Combaret,et al.  A leucine supplementation after an immobilization-induced atrophy in old rats enhanced protein anabolism but failed in muscle mass recovery , 2013 .

[2]  Jie-shou Li,et al.  Essential Amino Acid Enriched High-Protein Enteral Nutrition Modulates Insulin-Like Growth Factor-1 System Function in a Rat Model of Trauma-Hemorrhagic Shock , 2013, PloS one.

[3]  J. Tirapegui,et al.  Leucine supplementation increases serum insulin-like growth factor 1 concentration and liver protein/RNA ratio in rats after a period of nutritional recovery. , 2013, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[4]  M. Sheffield-Moore,et al.  Leucine supplementation chronically improves muscle protein synthesis in older adults consuming the RDA for protein. , 2012, Clinical nutrition.

[5]  G. Perdigón,et al.  Impact of a probiotic fermented milk in the gut ecosystem and in the systemic immunity using a non-severe protein-energy-malnutrition model in mice , 2011, BMC Gastroenterology.

[6]  S. Tanni,et al.  Anthropometric midarm measurements can detect systemic fat-free mass depletion in patients with chronic obstructive pulmonary disease. , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[7]  D. Dardevet,et al.  Long-term effects of leucine supplementation on body composition , 2010, Current opinion in clinical nutrition and metabolic care.

[8]  Nicholas Graves,et al.  The costs arising from pressure ulcers attributable to malnutrition. , 2010, Clinical nutrition.

[9]  J. Tirapegui,et al.  Leucine supplementation favors liver protein status but does not reduce body fat in rats during 1 week of food restriction. , 2010, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[10]  H. Sanada,et al.  The impact of malnutrition and nutrition-related factors on the development and severity of pressure ulcers in older patients receiving home care. , 2010, Clinical nutrition.

[11]  M. Tsujita,et al.  Protein-energy malnutrition halts hemopoietic progenitor cells in the G0/G1 cell cycle stage, thereby altering cell production rates. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[12]  D. Guttridge,et al.  The molecular mechanisms of skeletal muscle wasting: implications for therapy. , 2006, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[13]  N. Koren-Morag,et al.  Poor nutritional habits are predictors of poor outcome in very old hospitalized patients. , 2005, The American journal of clinical nutrition.

[14]  G. Ooi,et al.  The acid-labile subunit (ALS) of the 150 kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system. , 2001, The Journal of endocrinology.

[15]  L. Caregaro,et al.  Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders. , 2001, Clinical nutrition.

[16]  S. Yakar,et al.  The somatomedin hypothesis: 2001. , 2001, Endocrine reviews.

[17]  L. Caregaro,et al.  Tryptophan Levels, Excessive Exercise, and Nutritional Status in Anorexia Nervosa , 2000, Psychosomatic medicine.

[18]  H. Sugihara,et al.  Reduced growth hormone receptor messenger ribonucleic acid in an aged man with chronic malnutrition and growth hormone resistance. , 1999, The Journal of clinical endocrinology and metabolism.

[19]  R. Chandra,et al.  Nutrition and the immune system: an introduction. , 1997, The American journal of clinical nutrition.

[20]  J. Ketelslegers,et al.  Nutritional regulation of insulin-like growth factor-I. , 1995, Metabolism: clinical and experimental.

[21]  M. Cronin,et al.  Adaptation of the growth hormone and insulin-like growth factor-I axis to chronic and severe calorie or protein malnutrition. , 1995, The Journal of clinical investigation.

[22]  D. Clemmons,et al.  Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  L. Underwood,et al.  Reduction of insulin-like growth factor-I (IGF-I) in protein-restricted rats is associated with differential regulation of IGF-binding protein messenger ribonucleic acids in liver and kidney, and peptides in liver and serum. , 1994, Endocrinology.

[24]  J P McWhirter,et al.  Incidence and recognition of malnutrition in hospital , 1994, BMJ.

[25]  D. Straus,et al.  Induction of insulin-like growth factor binding protein-1 gene expression in liver of protein-restricted rats and in rat hepatoma cells limited for a single amino acid. , 1993, Endocrinology.

[26]  R. Humbel,et al.  Insulin-like growth factors I and II. , 1990, European journal of biochemistry.

[27]  L. Phillips,et al.  Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment. , 1985, The American journal of medicine.

[28]  D. Clemmons,et al.  Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content. , 1984, JPEN. Journal of parenteral and enteral nutrition.

[29]  A. Klibanski,et al.  Reduction of plasma immunoreactive somatomedin C during fasting in humans. , 1981, The Journal of clinical endocrinology and metabolism.

[30]  J. Argente,et al.  Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders. , 1997, Hormone research.

[31]  Z. Hochberg,et al.  The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. , 1992, Metabolism: clinical and experimental.

[32]  D. Straus,et al.  Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. , 1990, Molecular endocrinology.

[33]  L. Phillips,et al.  Nutrition and somatomedin. XV. Growth plate, growth factor and biologically active somatomedins in rats with streptozotocin-induced diabetes. , 1987, Annals of nutrition & metabolism.